Effectiveness of Modafinil in Improving Cognitive Performance of University Students

NCT ID: NCT01365897

Last Updated: 2011-06-03

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

PHASE4

Total Enrollment

128 participants

Study Classification

INTERVENTIONAL

Study Start Date

2010-09-30

Study Completion Date

2011-01-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The purpose of this study is to determine whether modafinil is effective in the improvement of mnesic performance and executive functions of university students from high academic performance.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Attention Memory, Short-Term Executive Function

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

CROSSOVER

Primary Study Purpose

TREATMENT

Blinding Strategy

TRIPLE

Participants Investigators Outcome Assessors

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Placebo

Control Group

Group Type PLACEBO_COMPARATOR

Modafinil

Intervention Type DRUG

Modafinil 200mg

Modafinil 200mg

Modafinil 200mg taken orally.

Group Type EXPERIMENTAL

Modafinil

Intervention Type DRUG

Modafinil 200mg

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Modafinil

Modafinil 200mg

Intervention Type DRUG

Other Intervention Names

Discover alternative or legacy names that may be used to describe the listed interventions across different sources.

Modafinilo

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Medicine, Psychology, Obstetrics, Nursing and Kinesiology students of the Universidad de Valparaiso.

Exclusion Criteria

* Patients with Mental Disorders.
* Patients with physical diseases.
* Patients using any psychotropic substances.
* History of chronic diseases.
* Pregnant women.
Minimum Eligible Age

18 Years

Maximum Eligible Age

25 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Universidad de Valparaiso

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Universidad de Valparaiso

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Alejandro Fernández, Psychologist

Role: PRINCIPAL_INVESTIGATOR

Universidad de Valparaiso

Eva Madrid, PhD

Role: STUDY_DIRECTOR

Universidad de Valparaiso

Andrés Painel, BM BCh

Role: STUDY_DIRECTOR

Universidad de Valparaiso

Jonathan Norambuena, BM BCh

Role: STUDY_DIRECTOR

Universidad de Valparaiso

Franco Mascayano, Psychologist

Role: STUDY_DIRECTOR

Universidad de Valparaiso

Walter Lips, Psychiatrist

Role: STUDY_DIRECTOR

Universidad de Valparaiso

Ortega Alonso, Psychologist

Role: STUDY_DIRECTOR

Universidad de Valparaiso

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Escuela de Medicina, Universidad de Valparaiso

Valparaíso, Región de Valparaíso, Chile

Site Status

Escuela de Psicología, Universidad de Valparaiso

Valparaíso, Región de Valparaíso, Chile

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Chile

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

04/2010

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Stimulant Effects on Brain Activity
NCT02453698 COMPLETED PHASE1